Previous Next


№4' 2019


International Medical Journal, Vol. 25., Iss. 4, 2019, P. 63−66.



Geis Asadli

National Centre of Oncology, Azerbaijan, Baku

The paper presents the treatment results performed in 250 patients with a laryngeal tumor of the third stage. The average life expectancy of these patients generally does not exceed 3−6 months. Chemotherapy is usually considered the standard treatment for the recurrence of head and neck squamous cell cancer patients, previously received radiotherapy. When prescribing the chemotherapy, a tumor regression is observed only in 10−40 % and does not virtually affect the life. Average life expectancy of these patients often varies from 5 to 9 months. The optimal total dose of radiotherapy for the treatment of inoperable recurrent and metastatic cancer was found in this reserach for imroving treatment results. The surgical protocols and techniques under discussion in this paper are certainly of a practical significance. The method for preoperative radiotherapy for larynx cancers was developed and the guidelines have been proven. Also there was proven that preoperative radiotherapy in a combined treatment of recurrent operable laryngeal cancer increases its effectiveness and does not affect postoperative period. Repeated radiotherapy for recurrent inoperable laryngeal cancer is possible only if the changes after previous radio− or combination therapy do not exceed 2 degrees. In addition, a repeated radiotherapy at a total source dose of 40−60 Gy is an effective method of palliative treatment and significantly improves the life expectancy and quality in the patients if compared with palliative chemotherapy. The method used in combination with intratumoral chemo− and radiotherapy significantly improves the efficiency of palliative treatment in the patients with recurrent regional metastasis for inoperable laryngeal cancer, in the primary tumor area, no signs of recurrence were found.

Key words: laryngeal cancer, combined cancer treatment, radiotherapy.


1. Long−term results of RTOG 91−11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer / A. Forastiere, Q. Zhang, R. Weber [et al.] // J. Clin. Oncol.− 2013.− Vol. 31 (7).− P. 856−863.

2. Paches A. I. Tumors of head and neck / A. I. Paches.− 2013.− R. 281−305.

3. Shah J. Head and Neck Surgery and Oncology / J. Shah, S. Patel, B. Singh.− 4th Edition.− 2012.− 856 p.

4. Polyakov P. Yu. Diagnosis of Tuberculosis Radiology in Clinical Oncology: Thesis for MD degree, Moscow, 2009.− 297 p.

5. Davydov M. I. Statistics of construction of the Russian Federation and the CIS countries in 2007 / M. I. Davydov, E. M. Axel // J. of N. N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences.− 2009.− Vol. 20, № 3 (77).− 158 p.

6. Patients with pulmonary artery thoracic aneurysm surgery / G. B. Adilbaev, D. H. Savkhatov, V. V. Shipilova, M. E. Kaybarov // Onkokhirurgiya.− 2008.− № 2.− P. 81−82.

7. Perspectives of using cetuximab in malignant tumors of large intestine, head and neck / S. V. Khokhlova, I. S. Romanov, V. A. Gorbunova [et al.] // Klinicheskaya Onkologiya.− Vol. 9, № 3.− P. 73−81

8. Prognostic factors in salvage surgery for oral recurrent and oropharyngeal cancer / I. M. Agra, A. L. Carvalho, F. S. Ulbrich [et al.] // Head &Neck.− 2006.− Vol. 28.− P. 107−113.

9. Salvage Reirradiation using Intensity−Modulated Radiotherapy for Squamous Cell Carcinoma of the Head and Neck / R. K. Chin, M. E. Daly, P. G. Maxim [et al.] // J. Radiat. Oncol. Biol. Phys.− 2008.− Vol. 72, № 1.− 420 p.

10. Re−irradiation in isolated neck recurrences management: Current status and recommendations / S. Chopra, T. Gupta, J. P. Agarwal [et al.] // Radiother. Oncol.− 2006.− № 81.− P. 1−8.

11. Cohen E. Role of epidermal growth factor receptor pathway−targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck / E.E. Cohen // J. Clin. Oncol.− 2006.− № 24 (17).− P. 2659−2665.

12. Colevas A. D. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck / A. D. Colevas // J. Clin. Oncol.− 2006.− № 24 (17).− P. 2644−2652.

13. Re−irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups / F. Janot, D. De Raucourt, M. Castaing [et al.] // J. Clin. Oncol.− 2006.− № 24.− P. 18.

14. Partial laryngectomy for recurrent glottic carcinoma after radiotherapy / A. Sewnaik, C. A. Meeuwis, T. H. Van der Kwast [et al.] // Head Neck.− 2005.− Vol. 27, № 2.− P. 101−107.

15. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy / W. Steiner, P. Vogt, P. Ambrosch [et al.] // Head Neck.− 2004.− Vol. 26, № 6.− P. 477−484.

16. Recurrent head and neck squamous cell carcinoma after primary curative surgery / L. Y. Wong, W. I. Wei, L. K. Lam [et al.] // Head Neck.− 2003.− Vol. 25.− P. 953−959.

17. Cox J. Functional outcome after reconstructive surgery / J. Cox // 8−International meeting "Diagnosis and Treatment Head and Neck Cancer", Netherlands.− Amsterdam, 2007.− P. 34−35.

18. Functional Irresectability, a realistic approch for functional sparing therapy in head and neck cancer? / A. Kreeft, I. B. Tan, M. W. Brekel, A. Balm // J. of. Clin. Oncology.− 2007.− № 1.− P. 398−403.

19. Reshetov I. V. Microsurgical reconstruction of laryngopharynx with voice rehabilitation / I. V. Reshetov, V. O. Olshansky, M. V. Ratushny // 8th International meeting "Diagnosis and Treatment of Head and Neck Cancer", the Netherlands.− Amsterdam, 2007.− P. 123.

20. Swallowing outcomes following laryngectomy and pharyngolaryngectomy / E. C. Ward, B. Bishop, J. Frisby, M. Stevens // Archives of Otolaryngology Head and Neck Surgery.− 2002.− P. 181−186.

21. Swallowing rehabilitation following total laryngectomy / E. C. Ward, S. M. Kerle [et al.] // Int. Conference Head and Neck Cancer: Treatment, Rehabilitation and Outcomes.− San Diego, 2007.− P. 243.

Go on Top